Previous studies indicated that the ERBB2 amplicon included STARD3 and GRB7 genes, and the co‐localization and co‐amplification of these genes with ERBB2 suggested a region of genomic amplification in breast cancer that extends beyond ERBB2.13, 14. This evidence concerns the gene ERBB2 and breast carcinoma.